Ricke, Jan-Niklas
Seifert, Roland
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
Article History
Received: 10 October 2024
Accepted: 7 November 2024
First Online: 25 November 2024
Declarations
:
: R.S. is the Editor-in-Chief of Naunyn-Schmiedebergs Arch Pharmacol and follows the editorial guidelines of the journal for editors acting as author ().
: Not applicable because publicly available information is used as data source.
: This research was conducted according to the guidelines of good scientific practice of the Hannover Medical School () and officially registered as doctoral thesis project for Jan-Niklas Ricke. The Hannover Medical School follows the guidelines of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG).